论文部分内容阅读
2010年全球批准上市的新分子实体(new molecular entity,NME)15个、新生物药品(newbiologics)9个,共24个(表1)。其中,遗传病治疗药4个、抗肿瘤药3
In 2010, 15 new molecular entities (NMEs) were approved for listing in the world and 9 of them were newbiologics (total 24) (Table 1). Among them, genetic disease treatment drugs 4, 3 anti-tumor drugs